These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 6341257)

  • 1. Hemofiltration in diabetic uremic patients.
    Segoloni GP; Pacitti A; Squiccimarro G; Triolo G; Ragni R; Vercellone A; Civati G; Guastoni C; Perego A; Teatini U; Minetti L; Carta Q
    Int J Artif Organs; 1983 Jan; 6(1):15-9. PubMed ID: 6341257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Continuous ambulatory peritoneal dialysis treatment and blood glucose control in diabetics with end-stage diabetic nephropathy].
    Li GW; Liu J; Chen L
    Zhonghua Nei Ke Za Zhi; 1989 Jun; 28(6):360-3, 382. PubMed ID: 2684575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving the course of diabetic nephropathy.
    Friedman EA
    Contrib Nephrol; 1985; 44():173-93. PubMed ID: 3886283
    [No Abstract]   [Full Text] [Related]  

  • 4. Maintenance peritoneal dialysis as an alternative in the patient with diabetes mellitus and end-stage uremia.
    Blumenkrantz MJ; Shapiro DJ; Mimura N; Greopoulus DG; Griedler RM; Levin S; Tenckhoff H; Coburn JW
    Kidney Int Suppl; 1974 Oct; (1):108-14. PubMed ID: 4533905
    [No Abstract]   [Full Text] [Related]  

  • 5. Maintenance dialysis for diabetic nephropathy with uremia.
    Huang C; del Greco F; Ivanovich P; Krumlovsky FA; Roguska J; Simon NM; Hano J
    J Chronic Dis; 1975 Aug; 28(7-8):365-74. PubMed ID: 169277
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of biofiltration versus hemofiltration in the treatment of chronic uremia.
    Cappelli G; Icardi A; Lamperi D; Lamperi S
    Int J Artif Organs; 1986 Dec; 9 Suppl 3():21-4. PubMed ID: 3557667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xylitol as osmotic agent in CAPD: an alternative to glucose for uremic diabetic patients?
    Bazzato G; Coli U; Landini S; Fracasso A; Morachiello P; Righetto F; Scanferla F; Onesti G
    Trans Am Soc Artif Intern Organs; 1982; 28():280-6. PubMed ID: 6761936
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies of carbohydrate metabolism after hemodialysis and hemofiltration in uremic patients.
    Geronemus R; Bosch JP; Thornton J; Rayfield EJ
    Arch Intern Med; 1982 Apr; 142(4):707-10. PubMed ID: 7041844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of treatment time with high flux postdilutional hemofiltration (HF).
    Mion C; Beau MC; Deschodt G; Gullberg CA; Ramperez P; Shaldon S
    Proc Clin Dial Transplant Forum; 1979; 9():63-5. PubMed ID: 552056
    [No Abstract]   [Full Text] [Related]  

  • 10. [Substitutive treatment of the uremic diabetic. 8 years of experience and new prospects].
    Triolo G; Thea A; Carta Q; Stratta P; Vacha GM; Giorda G; Paola M; Segoloni GP; Piccoli G; Vercellone A
    Minerva Nefrol; 1981; 28(3):315-20. PubMed ID: 7329609
    [No Abstract]   [Full Text] [Related]  

  • 11. CAPD in diabetics: use of aminoacids.
    Renzo S; Beatrice D; Giuseppe I
    Adv Perit Dial; 1990; 6():53-5. PubMed ID: 1982840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elimination of hormones through hemofiltration.
    Matthaei D; Kramer P; Langescheid C; McIntosh C; Schwinn G; Ebert R; Arnold R; Schauder G; Scheler F
    J Dial; 1977; 1(6):641-9. PubMed ID: 608873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of autonomic failure on plasma ANF concentration in uremic patients on chronic hemodialysis.
    Zoccali C; Mallamaci F; Ciccarelli M; Parlongo S; Salnitro F
    Clin Nephrol; 1992 Apr; 37(4):198-203. PubMed ID: 1533821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of adiponectin with cardiovascular events in diabetic and non-diabetic hemodialysis patients.
    Elokely A; Shoukry A; Ghonemy TA; Atia M; Amr G
    Saudi J Kidney Dis Transpl; 2012 Jul; 23(4):736-42. PubMed ID: 22805386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of renin in diabetic patients under chronic dialysis treatment.
    Kaneda H; Matsumoto J; Haruyama T; Yoshikawa K; Takeuchi M; Murata T
    Tohoku J Exp Med; 1979 Feb; 127(2):169-75. PubMed ID: 760263
    [No Abstract]   [Full Text] [Related]  

  • 16. High-tone external muscle stimulation in end-stage renal disease: effects on symptomatic diabetic and uremic peripheral neuropathy.
    Klassen A; Di Iorio B; Guastaferro P; Bahner U; Heidland A; De Santo N
    J Ren Nutr; 2008 Jan; 18(1):46-51. PubMed ID: 18089443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of erythropoietin and aminoguanidine on red blood cell deformability in diabetic azotemic and uremic patients.
    Brown CD; Zhao ZH; Thomas LL; deGroof R; Friedman EA
    Am J Kidney Dis; 2001 Dec; 38(6):1414-20. PubMed ID: 11728984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical imperatives in diabetic nephropathy.
    Friedman EA
    Kidney Int Suppl; 1983 May; (14):S-16-9. PubMed ID: 6348371
    [No Abstract]   [Full Text] [Related]  

  • 19. Simultaneous hemofiltration/hemodialysis: an effective alternative to hemofiltration and conventional hemodialysis in the treatment of uremic patients.
    Leber HW; Wizemann V; Goubeaud G; Rawer P; Schütterle G
    Clin Nephrol; 1978 Mar; 9(3):115-21. PubMed ID: 639371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrafiltration without dialysis for removal of fluid and solutes in uremia.
    Bergström J
    Clin Nephrol; 1978 Apr; 9(4):156-64. PubMed ID: 648043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.